AGM Statement

Summary by AI BETAClose X

MYCELX Technologies Corporation announced at its AGM that its opportunity pipeline has increased by 200% from January to August, now including 11 potential project awards with two US super majors and one Middle Eastern producer expected in the next 6-12 months, valued between $20 million and $22 million. The company has secured approval from a global integrated oil company, adding to existing approvals from two other major oil producers, which is expected to facilitate future project inclusions. While the timing of contract awards will impact revenue recognition, the company's expectations for the current financial year remain unchanged, subject to contract delivery by year-end.

Disclaimer*

MyCelx Technologies Corporation
17 September 2026
 

17 September 2026

 

MYCELX Technologies Corporation

("MYCELX" or the "Company")

 

AGM Statement

 

MYCELX Technologies Corporation (AIM: MYX), a leading provider of proprietary water treatment technology to the Oil and Gas and other industries worldwide, announces that, at the Company’s Annual Meeting (‘AGM’) to be held at 2:00 p.m. today, Tom Lamb, Chairman, will make the following statement.

 

"The Company stands at a key inflection point that reflects a number of years of hard work by the team. As noted in the interim results, the last 8 months have seen a massive expansion of the quality and size of the opportunity pipeline.

 

Key to this increased momentum has been the approval of the Company’s technology by a global integrated oil company, adding to the two existing approvals from a leading Middle Eastern producer and another global integrated oil company. This validation takes a considerable amount of time and resources but smooths the path to inclusion in future projects.

 

The Company has seen a 200% increase in the opportunity pipeline from January to August of this year. The pipeline includes 11 potential project awards with two US super majors and one Middle Eastern producer expected to be awarded in the next 6-12 months and worth a total of $20 million - $22 million. The timing of contract awards will dictate delivery and revenue recognition.

 

While we may not win all these contracts, MYCELX is well qualified to deliver them and has built strong relationships with these high quality customers giving  the Company confidence that it is well positioned to be awarded a material proportion of them, as well as others in the broader pipeline.

 

The Board’s expectations for the current financial year remain unchanged, but are subject to timing of the expected award of a contract and it’s delivery by year-end.”

 

For further information, please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Giles Balleny / Callum Davidson / Elysia Bough (Corporate Finance)

Harriet Ward (Corporate Broking)

Jasper Berry / Michael Johnson (Sales)

 

Tel: +44 20 7220 0500

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings